Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $1.78 billion. The enterprise value is $2.17 billion.
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 105.58 million shares outstanding. The number of shares has increased by 10.78% in one year.
| Current Share Class | 105.58M |
| Shares Outstanding | 105.58M |
| Shares Change (YoY) | +10.78% |
| Shares Change (QoQ) | +16.34% |
| Owned by Insiders (%) | 4.31% |
| Owned by Institutions (%) | 92.10% |
| Float | 94.61M |
Valuation Ratios
The trailing PE ratio is 26.43 and the forward PE ratio is 19.90.
| PE Ratio | 26.43 |
| Forward PE | 19.90 |
| PS Ratio | 0.81 |
| Forward PS | 1.20 |
| PB Ratio | 1.18 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | 15.49 |
| P/OCF Ratio | 10.15 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 47.05, with an EV/FCF ratio of 18.91.
| EV / Earnings | 33.40 |
| EV / Sales | 0.99 |
| EV / EBITDA | 47.05 |
| EV / EBIT | 2,075.28 |
| EV / FCF | 18.91 |
Financial Position
The company has a current ratio of 4.63, with a Debt / Equity ratio of 0.70.
| Current Ratio | 4.63 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 5.15 |
| Debt / FCF | 9.11 |
| Interest Coverage | 0.02 |
Financial Efficiency
Return on equity (ROE) is 4.91% and return on invested capital (ROIC) is 0.07%.
| Return on Equity (ROE) | 4.91% |
| Return on Assets (ROA) | 0.02% |
| Return on Invested Capital (ROIC) | 0.07% |
| Return on Capital Employed (ROCE) | 0.04% |
| Weighted Average Cost of Capital (WACC) | 4.93% |
| Revenue Per Employee | $2.62M |
| Profits Per Employee | $77,913 |
| Employee Count | 835 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.76 |
Taxes
| Income Tax | -40.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.49% in the last 52 weeks. The beta is 0.21, so SRPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -3.49% |
| 50-Day Moving Average | 18.31 |
| 200-Day Moving Average | 19.69 |
| Relative Strength Index (RSI) | 49.08 |
| Average Volume (20 Days) | 3,762,640 |
Short Selling Information
The latest short interest is 25.17 million, so 23.84% of the outstanding shares have been sold short.
| Short Interest | 25.17M |
| Short Previous Month | 25.13M |
| Short % of Shares Out | 23.84% |
| Short % of Float | 26.60% |
| Short Ratio (days to cover) | 8.99 |
Income Statement
In the last 12 months, SRPT had revenue of $2.18 billion and earned $65.06 million in profits. Earnings per share was $0.64.
| Revenue | 2.18B |
| Gross Profit | 470.80M |
| Operating Income | 1.05M |
| Pretax Income | 24.47M |
| Net Income | 65.06M |
| EBITDA | 46.18M |
| EBIT | 1.05M |
| Earnings Per Share (EPS) | $0.64 |
Full Income StatementBalance Sheet
The company has $653.19 million in cash and $1.05 billion in debt, giving a net cash position of -$393.86 million or -$3.73 per share.
| Cash & Cash Equivalents | 653.19M |
| Total Debt | 1.05B |
| Net Cash | -393.86M |
| Net Cash Per Share | -$3.73 |
| Equity (Book Value) | 1.51B |
| Book Value Per Share | 14.26 |
| Working Capital | 1.81B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $175.28 million and capital expenditures -$60.40 million, giving a free cash flow of $114.87 million.
| Operating Cash Flow | 175.28M |
| Capital Expenditures | -60.40M |
| Depreciation & Amortization | 45.14M |
| Net Borrowing | -159.38M |
| Free Cash Flow | 114.87M |
| FCF Per Share | $1.09 |
Full Cash Flow StatementMargins
Gross margin is 21.55%, with operating and profit margins of 0.05% and 2.98%.
| Gross Margin | 21.55% |
| Operating Margin | 0.05% |
| Pretax Margin | 1.12% |
| Profit Margin | 2.98% |
| EBITDA Margin | 2.11% |
| EBIT Margin | 0.05% |
| FCF Margin | 5.26% |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.78% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.66% |
| FCF Yield | 6.46% |
Analyst Forecast
The average price target for SRPT is $22.00, which is 30.56% higher than the current price. The consensus rating is "Hold".
| Price Target | $22.00 |
| Price Target Difference | 30.56% |
| Analyst Consensus | Hold |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | -13.92% |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
SRPT has an Altman Z-Score of 0.28 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.28 |
| Piotroski F-Score | 7 |